Literature DB >> 18706035

Reducing stroke risk in hypertensive patients: Asian Consensus Conference recommendations.

Li Sheng Liu1, Eduardo S Caguioa, Chang-Gyu Park, David Kwang Leng Quek, Ikuo Saito, Narayanaswamy Venketasubramanian, Ka Sing Lawrence Wong, John L Reid.   

Abstract

Stroke results in substantial morbidity and mortality globally. Asia-Pacific countries bear a disproportionate share of the burden of stroke, a burden that will grow as their populations' life expectancies rise. Hypertension is the single most important reversible risk factor for stroke, and effective measures to reduce blood pressure contribute significantly to reducing the incidence of stroke. The Asia-Pacific Consensus Conference on Stroke Prevention in Hypertensive Patients assembled leading experts from the region to reach an actionable consensus aimed at reducing stroke-induced morbidity and mortality in Asia through the evidence-based treatment of hypertension. The discussions of the group focused on how best to improve blood pressure control, how to promote lifestyle changes at the population level, and how to reduce the clinical and health system barriers and other challenges facing developing and low-income countries. The experts concluded that physicians must place an increased priority on reducing their patients' risk of stroke and recognise that all hypertensive patients are at greater risk of having a stroke compared with nonhypertensive individuals. They advocated that physicians must educate hypertensive patients about the risk of stroke, promote lifestyle modification to all patients diagnosed with hypertension, and prescribe rigorous antihypertensive treatment to get patients to recommended blood pressure goals.

Entities:  

Mesh:

Year:  2006        PMID: 18706035     DOI: 10.1111/j.1747-4949.2006.00041.x

Source DB:  PubMed          Journal:  Int J Stroke        ISSN: 1747-4930            Impact factor:   5.266


  7 in total

1.  Efficacy and tolerability of long-acting nifedipine GITS/OROS monotherapy or combination therapy in hypertensive patients: results of a 12-week international, prospective, multicentre, observational study.

Authors:  Kwo-Chang Ueng; Sun Ningling; Abd El Maksod; Kuan-Yu Hung; Yin Yuehui
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

2.  Pharmacological effects of Salvia miltiorrhiza (Danshen) on cerebral infarction.

Authors:  Tsai-Hui Lin; Ching-Liang Hsieh
Journal:  Chin Med       Date:  2010-06-21       Impact factor: 5.455

3.  Effect of Danshen aqueous extract on serum hs-CRP, IL-8, IL-10, TNF-α levels, and IL-10 mRNA, TNF-α mRNA expression levels, cerebral TGF-β1 positive expression level and its neuroprotective mechanisms in CIR rats.

Authors:  Xue-Yun Liang; Hai-Ning Li; Xiao-Yan Yang; Wen-Yan Zhou; Jian-Guo Niu; Ben-Dong Chen
Journal:  Mol Biol Rep       Date:  2013-02-02       Impact factor: 2.316

4.  Pharmacological effects of Radix Angelica Sinensis (Danggui) on cerebral infarction.

Authors:  Yi-Chian Wu; Ching-Liang Hsieh
Journal:  Chin Med       Date:  2011-08-25       Impact factor: 5.455

5.  Correlation between Echo-Tracking Parameters and In Vitro Measurements of Arterial Contraction and Relaxation in Rats Fed a High-Cholesterol Diet.

Authors:  Yi Zhang; Wei-Wei Zhan; Yong-Jie Wu; Bo Zhao; Wu-Gang Zhou; Dong-Rui Chen; Wei Zhou; Zhen-Hua Liu; Wei-Min Jiang; Lin Zheng
Journal:  Med Sci Monit       Date:  2015-09-30

6.  Perception of hypertension management by patients and doctors in Asia: potential to improve blood pressure control.

Authors:  Abdul Rashid Abdul Rahman; Ji-Guang Wang; Gary Mak Yiu Kwong; Dante D Morales; Piyamitr Sritara; Renan Sukmawan
Journal:  Asia Pac Fam Med       Date:  2015-02-11

7.  Hospital admissions for hypertensive crisis in the emergency departments: a large multicenter Italian study.

Authors:  Giuliano Pinna; Claudio Pascale; Paolo Fornengo; Sebastiana Arras; Carmela Piras; Pietro Panzarasa; Gianpaolo Carmosino; Orietta Franza; Vincenzo Semeraro; Salvatore Lenti; Susanna Pietrelli; Sergio Panzone; Christian Bracco; Roberto Fiorini; Giovanni Rastelli; Daniela Bergandi; Bruno Zampaglione; Roberto Musso; Claudio Marengo; Giancarlo Santoro; Sergio Zamboni; Barbara Traversa; Maddalena Barattini; Graziella Bruno
Journal:  PLoS One       Date:  2014-04-02       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.